Orchestra BioMed appoints John Mack to board of directors
PremiumThe FlyOrchestra BioMed appoints John Mack to board of directors
4M ago
Orchestra BioMed initiated with Buy, $15 target at B. Riley
Premium
The Fly
Orchestra BioMed initiated with Buy, $15 target at B. Riley
4M ago
Orchestra BioMed initiated with a Buy at B. Riley
Premium
The Fly
Orchestra BioMed initiated with a Buy at B. Riley
4M ago
Orchestra BioMed Showcases Progress at Investor Conferences
PremiumCompany AnnouncementsOrchestra BioMed Showcases Progress at Investor Conferences
5M ago
Orchestra BioMed files $300M mixed securities shelf
Premium
The Fly
Orchestra BioMed files $300M mixed securities shelf
6M ago
Orchestra BioMed reports Q1 EPS (38c) with items, consensus (40c)
Premium
The Fly
Orchestra BioMed reports Q1 EPS (38c) with items, consensus (40c)
6M ago
Orchestra BioMed Unveils Investor Presentation Update
PremiumCompany AnnouncementsOrchestra BioMed Unveils Investor Presentation Update
8M ago
Orchestra BioMed announces presentation of results from study on AVIM therapy
Premium
The Fly
Orchestra BioMed announces presentation of results from study on AVIM therapy
8M ago
Orchestra BioMed presents new data on long-term effect of AVIM therapy
Premium
The Fly
Orchestra BioMed presents new data on long-term effect of AVIM therapy
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100